BACKGROUND AND PURPOSE: Recent studies showed thalamic atrophy in the early stages of MS. We investigated the impact of intracortical lesions on the volumes of subcortical structures (especially the thalamus) compared with other lesions in MS.
MATERIALS AND METHODS:Seventy-one patients with MS were included. The volumes of intracortical lesions and white matter lesions were identified on double inversion recovery and FLAIR, respectively, by using 3D Slicer. Volumes of white matter T1 hypointensities and subcortical gray matter, thalamus, caudate, putamen, and pallidum volumes were calculated using FreeSurfer. Age, MS duration, and the Expanded Disability Status Scale score were assessed.
RESULTS:Patients with intracortical lesions were older (P ¼ .003), had longer disease duration (P , .001), and higher Expanded Disability Status Scale scores (P ¼ .02). The presence of intracortical lesions was associated with a significant decrease of subcortical gray matter volume (P ¼ .02). In our multiple regression model, intracortical lesion volume was the only predictor of thalamic volume (R 2 ¼ 0.4, b* ¼ -0.28, P ¼ .03) independent of white matter lesion volume and T1 hypointensity volume. White matter lesion volume showed an impact on subcortical gray matter volume in patients with relapsing-remitting MS (P ¼ .04) and those with disease duration of ,5 years (P ¼ .04) and on thalamic volume in patients with Expanded Disability Status Scale scores of ,4.0 (P ¼ .01). By contrast, intracortical lesion volume showed an impact on subcortical gray matter and thalamic volumes in the secondary-progressive MS subgroup (P ¼ .02 and P , .001) in patients with a long-standing disease course (P , .001 and P ¼ .001) and more profound disability (P , .001 and P , .001).CONCLUSIONS: Thalamic atrophy was explained better by intracortical lesions than by white matter lesion and T1 hypointensity volumes, especially in patients with more profound disability. ABBREVIATIONS: DIR ¼ double inversion recovery; EDSS ¼ Expanded Disability Status Scale; iCL ¼ intracortical lesion; ICV ¼ intracranial volume; PPMS ¼ primary-progressive MS; RRMS ¼ relapsing-remitting MS; SPMS ¼ secondary-progressive MS; T1H ¼ T1 hypointensities; WMH ¼ white matter hypointensities; WML ¼ white matter lesions; SGMS ¼ subcortical grey matter structures; b* ¼ standartized regression coefficients